Letteratura scientifica selezionata sul tema "IGF Type 2"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "IGF Type 2".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Articoli di riviste sul tema "IGF Type 2"
Hansenne, Isabelle Sylvie, Chantal Renard e Vincent Geenen. "Igf2 expression is required for complete tolerance to insulin (128.19)". Journal of Immunology 178, n. 1_Supplement (1 aprile 2007): S213—S214. http://dx.doi.org/10.4049/jimmunol.178.supp.128.19.
Testo completoBallard, F. J., M. Ross, F. M. Upton e G. L. Francis. "Specific binding of insulin-like growth factors 1 and 2 to the type 1 and type 2 receptors respectively". Biochemical Journal 249, n. 3 (1 febbraio 1988): 721–26. http://dx.doi.org/10.1042/bj2490721.
Testo completoLouis, Céline, Chantal Renard, Alain Bosseloir, Ilse Weets, Frans Gorus e Vincent Geenen. "Humoral and cellular immune responses to IGF-2 in type 1 diabetes (128.21)". Journal of Immunology 178, n. 1_Supplement (1 aprile 2007): S214. http://dx.doi.org/10.4049/jimmunol.178.supp.128.21.
Testo completoRosenzweig, Steven A. "The Continuing Evolution of Insulin-like Growth Factor Signaling". F1000Research 9 (23 marzo 2020): 205. http://dx.doi.org/10.12688/f1000research.22198.1.
Testo completoAl-janaby, Mohammed Salih, Mohammed Qais Al-ani e Marrib N. Rasheed. "RELATIONSHIP BETWEEN SOME IMMUNOLOGICAL FACTORS AND TYPE 2 DIABETES MELLITUS IN IRAQI PATIENTS". Asian Journal of Pharmaceutical and Clinical Research 11, n. 6 (7 giugno 2018): 489. http://dx.doi.org/10.22159/ajpcr.2018.v11i6.25881.
Testo completoBallard, F. J., L. C. Read, G. L. Francis, C. J. Bagley e J. C. Wallace. "Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts". Biochemical Journal 233, n. 1 (1 gennaio 1986): 223–30. http://dx.doi.org/10.1042/bj2330223.
Testo completoSchuller, A. G. P., J. W. van Neck, R. W. Beukenholdt, E. C. Zwarthoff e S. L. S. Drop. "IGF, type I IGF receptor and IGF-binding protein mRNA expression in the developing mouse lung". Journal of Molecular Endocrinology 14, n. 3 (giugno 1995): 349–55. http://dx.doi.org/10.1677/jme.0.0140349.
Testo completoWasim, H., M. Abdelmonem, S. Samir e A. Salah. "Monitoring Of IGF-1 Levels In Type 2 Diabetic Patients With Macro And Microvascular Complications". American Journal of Clinical Pathology 154, Supplement_1 (ottobre 2020): S127—S128. http://dx.doi.org/10.1093/ajcp/aqaa161.279.
Testo completoNarayanan, Ram P., Matthew Gittins, Kirk W. Siddals, Robert L. Oliver, Julie E. Hudson, Anne White, Paul Durrington, Robert R. Davies, Martin K. Rutter e J. Martin Gibson. "Atorvastatin administration is associated with dose-related changes in IGF bioavailability". European Journal of Endocrinology 168, n. 4 (aprile 2013): 543–48. http://dx.doi.org/10.1530/eje-12-0844.
Testo completoKirk, S. P., M. A. Whittle, J. M. Oldham, P. M. Dobbie e J. J. Bass. "GH regulation of the Type 2 IGF receptor in regenerating skeletal muscle of rats". Journal of Endocrinology 149, n. 1 (aprile 1996): 81–91. http://dx.doi.org/10.1677/joe.0.1490081.
Testo completoTesi sul tema "IGF Type 2"
Boulle, Nathalie. "Analyse du système des insulin-like growth factors (IGF) et du fibroblast growth factor-2 (FGF-2) dans la tumorigenèse corticosurrenalienne". Paris 11, 2000. http://www.theses.fr/2000PA11T006.
Testo completoLn adrenocortical tumors, malignant phenotype is associated with abnormalities at the 11p15 locus and overexpression of the IGF-11 gene. Here, we show that IGF-11 mRNA is efficiently translated and that malignant adrenocortical tumors contain large amounts of IGF-11 protein, mainly in its prohormone form. The same tumors exhibit a high content in IGFBP-2 protein, an IGFBP being frequently expressed in tumor cells. The H295R cell line, which is derived from a human adrenal carcinoma, express high levels of both IGF-11 and IGFBP-2 and represents a suitable in vitro model to study adrenocortical tumorigenesis. Using this cell line, we could demonstrate that IGF-11 is involved in the proliferation of adrenocortical tumor cells, after binding to the type 1 IGF receptor. The interest of plasma IGFBP-2 as a marker for adrenocortical carcinoma was evaluated. Our results show that high levels of IGFBP-2 are specifically detected in the plasma of patients with malignant adrenocortical tumors. However, the increase in IGFBP-2 levels occur at a late stage of tumor progression (metastatic stage). This indicates a poor sensitivity for plasma IGFBP-2, which may limit its interest as a tumor marker. We also studied the effects of FGF-2 on adrenocortical tumor cells. Our results indicate that FGF-2 is mitogenic for H295R cells, although it inhibits the expression of both IGF-11 and IGFBP-2 by these cells. The inhibition of IGFBP-2 expression occur at the transcriptional levels. Ln contrast, FGF-2 inhibits the secretion and the last steps of maturation of the IGF-11 precursor. Altogether, these results suggest that in malignant adrenocortical tumors, various factors may modulate the expression (FGF-2) or the effects (IGFBP-2) of IGF-11 on adrenocortical tumor cells
Narayanan, Ram. "Genotype and phenotype interactions of the insulin-like growth factor system in type 2 diabetes". Thesis, University of Manchester, 2013. https://www.research.manchester.ac.uk/portal/en/theses/genotype-and-phenotype-interactions-of-the-insulinlike-growth-factor-system-in-type-2-diabetes(5e6925fb-195d-47d8-a06d-8957a8f3b86f).html.
Testo completoO'Reilly, Kathryn Elizabeth. "Integration of mtor and IGF-1 signaling : feedback upregulation of survival pathways in human cancer cells /". Access full-text from WCMC:, 2007. http://proquest.umi.com/pqdweb?did=1296100571&sid=11&Fmt=2&clientId=8424&RQT=309&VName=PQD.
Testo completoTrivedi, Harsha N. "Characterization of type-1/type-2 cytokine and IgE responses of HIV-1 resistant Kenyan women, characterization of neonatal type-1/type-2 cytokine responses". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape17/PQDD_0002/NQ32027.pdf.
Testo completoRøge, Rikke Meldgaard. "Pharmacometric Models of Glucose Homeostasis in Healthy Subjects and Diabetes Patients". Doctoral thesis, Uppsala universitet, Institutionen för farmaceutisk biovetenskap, 2016. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-274239.
Testo completoGodefroy, Anastasia. "Nouvelle stratégie d'enzymothérapie substitutive ciblant le récepteur du mannose 6-phosphate pour les maladies lysosomales". Thesis, Montpellier, 2019. http://www.theses.fr/2019MONTT030.
Testo completoLysosomal diseases form a heterogeneous group of about fifty rare diseases. At present, only 9 lysosomal diseases have a specific treatment, mainly by enzyme replacement therapy but the beneficial effects appear often limited. The lack of targeting for the Mannose 6-Phosphate Receptor (M6PR), responsible for internalization into the lysosomes, would partly explain this moderate efficiency of the therapeutic enzymes. In this context, we have developed an innovative targeting approach based on Mannose 6-Phosphate Synthetic Analogues Functionalized at the Aglycone position (called AMFAs) to address the unmet needs of current treatments.The work of this thesis focuses mainly on Pompe disease which is a myopathy caused by the deficiency of a lysosomal enzyme, Acid Alpha Glucosidase (GAA), responsible for the conversion of glycogen into glucose. In order to improve the targeting of the therapeutic enzyme to lysosomes via the M6PR, we have functionalized the human recombinant GAA (rhGAA) with the AMFAs. Our studies on aged mice model of the adult form of the disease have demonstrated a significant increase of the enzyme internalization and for the first time, the restoration of muscle health and the significant improvement in motor function (article 1). We then investigated the properties of rhGAA-AMFA. We have proved that the effectiveness of rhGAA-AMFA is not only due to a better cell uptake but also to a more complete intracellular processing of the enzyme (article 2). Indeed, our results demonstrated that in myoblasts of patients affected by Pompe disease there is an overexpression of ACP2 and ACP5 acid phosphatases. These phosphatases can destroy the mannose 6-phosphate signal (M6P) naturally present on the enzyme, therefore possibly interrupting its processing into the active form. AMFA, unlike M6P, is insensitive to this degradation and thus ensures the stability of enzyme addressing in vitro, but also in vivo.All together, these results suggest that the grafting of the AMFAs on recombinant enzymes represents a new therapeutic solution for the treatment of Pompe disease and potentially for other lysosomal diseases
Fabris, Chiara. "Glucose variability assessment in diabetes mellitus monitoring and control". Doctoral thesis, Università degli studi di Padova, 2015. http://hdl.handle.net/11577/3424146.
Testo completoL'obiettivo di questa tesi è l'indagine del ruolo della variabilità glicemica (GV) nella patologia del diabete mellito. La GV è un fattore di rischio per lo sviluppo di complicazioni dal diabete, e la sua valutazione combinata con quella dei livelli di emoglobina glicata è ritenuta essere un elemento utile nel caratterizzare il funzionamento del metabolismo del glucosio. Data l'importanza della GV nel diabete, molteplici indicatori che permettono di ottenerne una quantificazione dall'analisi retrospettiva di segnali di self-monitoring of blood glucose (SMBG) o continuous glucose monitoring (CGM) sono stati proposti in letteratura, ma in merito esistono alcune problematiche ancora aperte. Per esempio, alcuni indici sono stati sviluppati specificamente per essere applicati su serie SMBG, ed il loro utilizzo su segnali CGM non è ancora stato validato. Inoltre, il fatto che esistano numerosi indicatori per quanticare la GV dà origine a problemi di ridondanza nell'informazione trasmessa, ed un approccio che permetta di ottenere una descrizione compatta ma esaustiva della GV sarebbe desiderabile. Infine, l'uso di segnali CGM e dell'informazione sulla GV per classificare lo stato metabolico di soggetti normali e diabetici è un problema relativamente inesplorato che potrebbe meritare di essere trattato. Questi tre argomenti sono l'oggetto di questa tesi, che risulta articolata in sei capitoli il cui contenuto è brevemente delineato di seguito. Il Capitolo 1 descriverà l'eziologia dei differenti tipi di diabete, discuterà lo sviluppo delle complicazioni da diabete, ed introdurrà le tecnologie utilizzate per monitorare la glicemia ed alcune strategie che si possono seguire per trattare il diabete mellito di tipo 1 (T1DM) e 2 (T2DM). Il Capitolo 2 verterà sulla GV e la sua quantificazione, e, dopo aver evidenziato i problemi aperti esistenti, dichiarerà precisamente gli scopi della tesi. Il Capitolo 3 considererà il problema di adattare alcuni indicatori di GV originariamente sviluppati e validati su profili SMBG, all'utilizzo su segnali CGM. In particolare, ci concentreremo su low blood glucose index (LBGI) e high blood glucose index (HBGI), indici popolari che permettono di ottenere una rapida classificazione della qualità del controllo glicemico in soggetti diabetici, e forniremo versioni alternative di questi indicatori adattate alle caratteristiche dei segnali CGM, modellando la relazione tra i valori che LBGI e HBGI assumono quando calcolati da SMBG e CGM. Un dataset di 28 soggetti T1DM monitorati con dispositivi SMBG e CGM sarà utilizzato per mettere a punto la metodologia. Il Capitolo 4 affronterà il problema della ridondanza nell'informazione fornita dagli indicatori di GV esistenti, utilizzando la sparse principal component analysis (SPCA) come approccio per fornire una descrizione parsimoniosa ma allo stesso tempo esaustiva della GV in popolazioni di soggetti con T1DM e T2DM. In particolare, considereremo 25 indicatori di GV valutati su profili CGM acquisiti da 33 soggetti con T1DM e 13 con T2DM come insieme iniziale di variabili. La SPCA sarà applicata a questo pool di indici e permetterà di selezionare un piccolo sottoinsieme di 10 indicatori che consente di preservare più del 60% della varianza originariamente spiegata dall'insieme di partenza in entrambe le applicazioni. Il sottoinsieme di indicatori fornito dalla SPCA può essere utilizzato per descrivere parsimoniosamente la GV nel diabete. Il Capitolo 5 sarà dedicato alla valutazione della possibilità di utilizzare gli output della SPCA per costruire classificatori dello stato metabolico di soggetti normali e diabetici basati sulla GV. In particolare, facendo ricorso ad un dataset di 55 soggetti con T1DM, 34 normali a rischio T2DM, 39 con impaired glucose tolerance, e 29 con T2DM diagnosticato, mostreremo che classificatori progettati su support vector machine sono capaci di discriminare con successo la qualità del controllo glicemico e la condizione metabolica di soggetti con disordini, permettendo di raggiungere un'accuratezza di classicazione sempre maggiore del 70%. Lo studio sarà condotto utilizzando sia il pool iniziale di 25 indicatori che il sottoinsieme parsimonioso fornito dalla SPCA come features per costruire i classificatori; il fatto che risultati simili siano ottenuti nei due casi rafforza la speculazione che la descrizione compatta della GV fornita dalla SPCA sia effettivamente esaustiva nel caratterizzare la condizione metabolica dei soggetti. Il Capitolo 6 chiuderà la tesi, con una discussione su possibili sviluppi futuri degli studi qui presentati.
Sjöblom, Johan, e Ulrik Malmberg. "Vägen till hälsa : Motivation till fysisk aktivitet hos patienter med förstadie till eller diagnostiserad diabetes typ 2". Thesis, Högskolan i Borås, Institutionen för Vårdvetenskap, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:hb:diva-16544.
Testo completoProgram: Sjuksköterskeutbildning
Kondo, Yaeko. "The study of plasma glucose level and insulin secretion capacity after glucose load in Japanese". Kyoto University, 2016. http://hdl.handle.net/2433/215958.
Testo completoToušková, Věra. "Úloha komponent osy GH/IGF-1 v etiopatogeneze metabolických odchylek u diabetes mellitus 2. typu a akromegalie". Doctoral thesis, 2016. http://www.nusl.cz/ntk/nusl-265165.
Testo completoLibri sul tema "IGF Type 2"
name, No. Diabetes sourcebook: Basic consumer health information about type 1 diabetes (insulin-dependent or juvenile-onset diabetes), type 2 diabetes (noninsulin-dependent or adult-onset diabetes), gestational diabetes, impaired glucose tolerance (IGT) ... 3a ed. Detroit, MI: Omnigraphics, 2003.
Cerca il testo completoD, Matthews Dawn, a cura di. Diabetes sourcebook: Basic consumer health information about Type 1 diabetes (insulin-dependent or juvenile-onset diabetes), Type 2 diabetes (noninsulin-dependent or adult-onset diabetes, gestational diabetes, impaired glucose tolerance (IGT), and related complications, such as amputation, eye disease, gum disease, nerve damage, and end-stage renal disease : including facts about insulin, oral diabetes medications, blood sugar testing, and the role of exercise and nutrition in the control of diabetes : along with a glossary and resources for further help and information. 3a ed. Detroit, Mich: Omnigraphics, 2003.
Cerca il testo completoType 2 Diabetes. Exon Publications, 2024. http://dx.doi.org/10.36255/type-2-diabetes.
Testo completoM¨uhlherr, Bernhard, Holger P. Petersson e Richard M. Weiss. Unramified Quadrangles of Type E6, E7 and E8. Princeton University Press, 2017. http://dx.doi.org/10.23943/princeton/9780691166902.003.0011.
Testo completoM¨uhlherr, Bernhard, Holger P. Petersson e Richard M. Weiss. Quadratic Forms of Type F4. Princeton University Press, 2017. http://dx.doi.org/10.23943/princeton/9780691166902.003.0009.
Testo completoM¨uhlherr, Bernhard, Holger P. Petersson e Richard M. Weiss. Semi-ramified Quadrangles of Type E6, E7 and E8. Princeton University Press, 2017. http://dx.doi.org/10.23943/princeton/9780691166902.003.0012.
Testo completoFabrizi, Fabrizio, e Patrice Cacoub. The patient with cryoglobulinaemia. A cura di Giuseppe Remuzzi. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0151.
Testo completoOkasha, Samir. Agential Thinking and its Rationale. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780198815082.003.0002.
Testo completoHedley, Steve, e Nicola Padfield. 2. Deliberate harm to the person. Oxford University Press, 2013. http://dx.doi.org/10.1093/he/9780199586561.003.0188.
Testo completoKatz, David L. The Integrative Preventive Medicine Approach to Obesity and Diabetes. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190241254.003.0018.
Testo completoCapitoli di libri sul tema "IGF Type 2"
Nissley, S. Peter. "Type 2 IGF Receptor-Mediated Events". In The IGF System, 165–97. Totowa, NJ: Humana Press, 1999. http://dx.doi.org/10.1007/978-1-59259-712-3_8.
Testo completoMoses, Alan C. "Insulin Resistance and Type 2 Diabetes mellitus: Is There a Therapeutic Role for IGF-1?" In IGF-I and IGF Binding Proteins, 121–34. Basel: KARGER, 2005. http://dx.doi.org/10.1159/000085762.
Testo completoSandhu, Manjinder S. "Insulin-Like Growth Factor-I and Risk of Type 2 Diabetes and Coronary Heart Disease: Molecular Epidemiology". In IGF-I and IGF Binding Proteins, 44–54. Basel: KARGER, 2005. http://dx.doi.org/10.1159/000085755.
Testo completoFayette, J., B. Fleury e J. Y. Blay. "Nouvelles approches dans les thérapeutiques ciblées: les récepteurs des facteurs de croissance de type insuline (IGF) et les cyclines". In Les thérapies ciblées, 157–68. Paris: Springer Paris, 2008. http://dx.doi.org/10.1007/978-2-287-36008-4_11.
Testo completoChiasson, Jean-Louis, Markku Laakso e Markolf Hanefeld. "Decreasing Postprandial Plasma Glucose Using an α-Glucosidase Inhibitor in Subjects with IGT for the Prevention of Type 2 Diabetes Mellitus: The STOP-NIDDM Trial". In Prevention of Type 2 Diabetes, 167–87. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-3314-9_10.
Testo completoCascieri, Margaret A., Gary G. Chicchi, Barbara G. Green, Joy Applebaum, Nancy S. Hayes e Marvin L. Bayne. "Analysis of the interaction of IGF I and structural mutants of IGF I with the IGF types 1 and 2 and insulin receptors". In Peptides, 570–71. Dordrecht: Springer Netherlands, 1988. http://dx.doi.org/10.1007/978-94-010-9595-2_170.
Testo completoRizqoh, Debie, Kristin Ronaniou Haloho, Enny Nugraheni, Widyawati, Utari Hartati e Riry Ambarsary. "The Influence of Type 2 Diabetes Mellitus Comorbidity Factors in COVID-19 Patients on IgM and IgG Antibody Levels of SARS-Cov-2 at M. Yunus Hospital and Harapan Dan Doa Hospital Bengkulu City". In Proceedings of the International Conference On Multidisciplinary Studies (ICOMSI 2022), 17–24. Paris: Atlantis Press SARL, 2023. http://dx.doi.org/10.2991/978-2-38476-072-5_3.
Testo completoAllais, Guillaume. "Builtin Types Viewed as Inductive Families". In Programming Languages and Systems, 113–39. Cham: Springer Nature Switzerland, 2023. http://dx.doi.org/10.1007/978-3-031-30044-8_5.
Testo completoAskenase, Philip W. "Delayed-Type Hypersensitivity Recruitment of T Cell Subsets via Antigen-Specific Non-IgE Factors or IgE Antibodies: Relevance to Asthma, Autoimmunity and Immune Responses to Tumors and Parasites (Part 2 of 2)". In Regulation and Functional Significance of T-Cell Subsets, 189–212. Basel: KARGER, 1992. http://dx.doi.org/10.1159/000319122.
Testo completoAbdrabo, Karim I., Sameh A. Kantosh, Mohamed Saber, Tetsuya Sumi, Dina Elleithy, Omar M. Habiba e Bahaa Alboshy. "The Role of Urban Planning and Landscape Tools Concerning Flash Flood Risk Reduction Within Arid and Semiarid Regions". In Natural Disaster Science and Mitigation Engineering: DPRI reports, 283–316. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-2904-4_11.
Testo completoAtti di convegni sul tema "IGF Type 2"
Zanarel, Palomali, Marina Grigoli, Danielle de Oliveira, Patrícia Manzine e Márcia Cominetti. "IFG-1 PLASMA LEVELS ARE ALTERED IN PATIENTS WITH ALZHEIMER’S DIASEASE AND DIABTES MELLITUS TYPE 2". In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda045.
Testo completoBid, Hemant K., Doris Phelps e Peter J. Houghton. "Abstract 3277: Insulin-like growth factor-2 (IGF-2) circumvents the antiangiogenic activity of SCH717454, a human antibody that blocks ligand binding to the Type 1 insulin-like growth factor receptor (IGF-1R)". In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3277.
Testo completoSetiawati, Yessy, Aswiyanti Asri e Rosfita Rasyid. "IGF-1R Expression has More Potential Proliferation Effect in Invasive Breast Carcinoma Of No Special Type Compared to HER-2 Expression". In Proceedings of the 1st EAI International Conference on Medical And Health Research, ICoMHER November 13-14th 2018, Padang, West Sumatera, Indonesia. EAI, 2019. http://dx.doi.org/10.4108/eai.13-11-2018.2283795.
Testo completoSilva, Bruno Vinícius Diniz e., Brunna Rodrigues de Oliveira, Larissa Silva Magalhães, Kamila Cardoso dos Santos, Livia Melo Vilar, Vanessa Salete de Paula, Karlla Antonieta Amorim Caetano, Sheila Araújo Teles e Megmar Aparecida dos Santos Carneiro. "Seroepidemiological study of herpes simplex virus type 2 (HSV-2) infection in transgender women in Goiás". In XIII Congresso da Sociedade Brasileira de DST - IX Congresso Brasileiro de AIDS - IV Congresso Latino Americano de IST/HIV/AIDS. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/dst-2177-8264-202133p058.
Testo completoGaffney, P. J., L. J. Creighton, A. Curry, B. MacMahon e R. Thorpe. "MONOCLONAL ANTIBODIES OF THE IgM AND IgG CLASS SPECIFIC FOR CROSSLINKED FIBRIN DEGRADATION PRODUCTS". In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643651.
Testo completoPicó, M., A. Ribera, C. Martin, J. Zuazu e J. Monasterio. "GLANZMANN'S THROMBASTHENIA IN PREGNANCY: CLINICAL FEATURES AND PLATELET SEROLOGY". In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644556.
Testo completoGardner, R., T. Moran e C. E. Loughlin. "Probable Follicular Bronchiolitis in Pediatric Patient with Hyper IgM Type 2 Syndrome". In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7181.
Testo completoStörkel, F., I. Scharrer, L. Hovy, J. Rüdigier e S. Störkel. "HAEMOPHILIC ARTHROPATHY: IMMUNOLOGICAL MECHANISMS AND SYNOVITIS". In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644023.
Testo completoFuqun, Chen, Li Wenlan, Wang Zongyuan e Cong Mengzi. "An Experimental Investigation of Response of a Turbojet Engine to Inlet Distortion". In ASME 1985 Beijing International Gas Turbine Symposium and Exposition. American Society of Mechanical Engineers, 1985. http://dx.doi.org/10.1115/85-igt-12.
Testo completoKazama, M., H. Ishii, J. Tsubouchi, M. Nakano, N. Hiramoto, T. Abe e P. W. Majerus. "PREPARATION OF ANTI-HUMAN THROMBOMODULIN ANTIBODIES AND THEIR APPLICATION FOR STUDY ON PLASMA THROMBOMODULIN". In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643962.
Testo completoRapporti di organizzazioni sul tema "IGF Type 2"
Funkenstein, Bruria, e Cunming Duan. GH-IGF Axis in Sparus aurata: Possible Applications to Genetic Selection. United States Department of Agriculture, novembre 2000. http://dx.doi.org/10.32747/2000.7580665.bard.
Testo completoWilliams, Thomas. Microbial Mating-type Matching memory Game. University of Dundee, 2023. http://dx.doi.org/10.20933/100001286.
Testo completoMeidan, Rina, e Robert Milvae. Regulation of Bovine Corpus Luteum Function. United States Department of Agriculture, marzo 1995. http://dx.doi.org/10.32747/1995.7604935.bard.
Testo completoSchick-Makaroff, Kara, Antoinette Davey, Mirjam Sprangers, Veronique Sébille, Rick Sawatzky e Response Shift in Sync Working Group. Protocol for a qualitative metasynthesis on response shift. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, febbraio 2023. http://dx.doi.org/10.37766/inplasy2023.2.0111.
Testo completoAn, Dayoung, e Seung-ho Sun. The Effect of laser therapy in treating post-stroke shoulder pain: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, gennaio 2023. http://dx.doi.org/10.37766/inplasy2023.1.0085.
Testo completoAndrian, Leandro Gaston, Oscar Valencia, Jorge Hirs e Ivan Leonardo Urrea Rios. Fiscal Rules and Economic Cycles: Quality (Always) Matters. Inter-American Development Bank, gennaio 2023. http://dx.doi.org/10.18235/0004570.
Testo completoLyons, Nicole, Ali Siddiqui, Oluwatunmininu Anwoju, Brianna Cohen, Walter Ramsey, Christopher O'Neil, Zuhair Ali e Mike Liang. Biologic versus Synthetic Mesh for Ventral Hernia Repair: a protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, ottobre 2022. http://dx.doi.org/10.37766/inplasy2022.10.0016.
Testo completoShi, Min, Yao Yao, Haifeng Ding, Jian Yang, Zhen Feng, Yingying Jiang e Tao Guo. The Pharyngeal Packs for Dental and Otolaryngological Surgery: A Meta-analysis of High-quality RCTs. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, febbraio 2023. http://dx.doi.org/10.37766/inplasy2023.2.0002.
Testo completoChust-Hernández, Pablo, Emelina López-González e Joan Maria Senent-Sánchez. Effectiveness of non-pharmacological treatments for academic stress in university students: a protocol for a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, luglio 2022. http://dx.doi.org/10.37766/inplasy2022.7.0071.
Testo completoZheng, You-you, Ning Liang, Long-kun Liu, Wei-jia Sun, Xue-hui Wang, Yu-xin Sun, Yun-ru Chen, Xiao-xia Han, Zhao-lan Liu e Jian-ping Liu. Effectiveness and Safety of Chinese Patent Medicine for Functional Constipation: A Systematic Review and Network-Meta Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, maggio 2022. http://dx.doi.org/10.37766/inplasy2022.5.0049.
Testo completo